Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: Long-term observations from International Breast Cancer Study Group Trial VI

Journal of Clinical Oncology

Volumn 23, Issue 28, 2005, Pages 7089-7097

  Gruber, Günther ^a   Bonetti, Marco ^b   Nasi, M Laura ^b   Price, Karen N ^b   Castiglione Gertsch, Monica ^b   Rudenstam, Carl Magnus ^b   Holmberg, Stig B ^b   Lindtner, Jurij ^b   Golouh, Rastko ^b   Collins, John ^b   Crivellari, Diana ^b   Carbone, Antonino ^b   Thürlimann, Beat ^b   Simoncini, Edda ^b   Fey, Martin F ^b   Gelber, Richard D ^b   Coates, Alan S ^b   Goldhirsch, Aron ^b  

^a Institute of Radiation Oncology   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; ANTINEOPLASTIC AGENT; CMF REGIMEN;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; AGED; BREAST TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; LYMPH NODE; MASTECTOMY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; POSTMENOPAUSE; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; METHOTREXATE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTMENOPAUSE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 27244447447     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.08.123     Document Type: Article

References (28)

1. Fisher ER, Palekar AS, Gregorio RM, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol No. 4), III: The significance of extranodal extension of axillary metastases. Am J Clin Pathol 65:439-444, 1976
2. Mambo NC, Gallager S: Carcinoma of the breast: The prognostic significance of extranodal extension of axillary disease. Cancer 39:2280-2285, 1977
3. Fisher BJ, Perera FE, Cooke AL, et al: Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: An indication for radiotherapy? Int J Radiat Oncol Biol Phys 38:551-559, 1997
4. Kahlert S, Boettcher B, Lebeau A, et al: Prognostic impact of extended extracapsular component in involved lymph nodes in primary breast cancer. Eur J Cancer 35:S89, 1999 (suppl 4, abstr 292)
5. Katz A, Strom EA, Buchholz TA, et al: Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 18:2817-2827, 2000
6. Donegan WL, Stine SB, Samter TG: Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 72:778-782, 1993
7. Leonard C, Corkill M, Tomkin J, et al: Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy. J Clin Oncol 13:47-53, 1995
8. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
9. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949-955, 1997
10. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
11. Ragaz J, Jackson S, Le N, et al: Postmastectomy radiation outcome in node positive breast cancer patients among N1-3 versus N4+ subset: Impact of extracapsular spread-Update of the British Columbia Randomized Trial. Proc Am Soc Clin Oncol 18:73a, 1999 (abstr 274)
12. Overgaard M: Update of the Danish trials of postoperative radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy, in Kogelnik HD, Lukas P, Sedlmayer F (eds): Progress in Radio-Oncology VII. Bologna, Italy, Monduzzi Editore S.p.A, 2002, pp 483-492
13. Recht A, Edge SB, Solin LJ, et al: Post-mastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539-1569, 2001
14. Goldhirsch A, Glick J, Gelber R, et al: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Clin Oncol 19:3817-3827, 2001
15. Hetelekidis S, Schnitt SJ, Silver B, et al: The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int J Radiat Oncol Biol Phys 46:31-34, 2000
16. The International Breast Cancer Study Group: Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. J Clin Oncol 14:1885-1894, 1996
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Cox DR: Regression models and life-tables. J R Stat Soc B, 34:187-220, 1972
19. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
20. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
21. Veronesi U, Rilke F, Luini A, et al: Distribution of axillary node metastases by level of invasion: An analysis of 539 cases. Cancer 59:682-687, 1987
22. Pierce LJ, Oberman HA, Strawderman MH, et al: Microscopic extracapsular extension in the axilla: Is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 33:253-259, 1995
23. Vicini FA, Horwitz EM, Lacerna MD, et al: The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 39:1069-1076, 1997
24. Fodor J, Toth J, Major T, et al: Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: Value of adjuvant irradiation. Int J Radiat Oncol Biol Phys 44:281-287, 1999
25. Jager JJ, Volovics L, Scheuten LJ, et al: Loco-regional recurrences after mastectomy in breast cancer: Prognostic factors and implications for postoperative irradiation. Radiother Oncol 50:267-275, 1999
26. Mignano JE, Zahurak ML, Chakravarthy A, et al: Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation. Cancer 86:1258-1262, 1999
27. Wallgren A, Bonetti M, Gelber RD, et al: Risk factors for locoregional recurrence among reast cancer patients: Results from International Breast Cancer Study Group trials I through VII. J Clin Oncol 21:1205-1213, 2003
28. Ragaz J, Phillips N, Spinelli J, et al: Extensive nodal involvement or extracapsular spread in predicting the survival impact of loco-regional radiation for stage II breast cancer patients: Long-term observations from the British Columbia randomized trial. Proc Am Soc Clin Oncol 20:12b, 2001 (abstr 1794)